Identifying steroid hormone receptor gene mutations in patients with newly diagnosed estrogen receptor positive metastatic breast cancer

被引：0
|
作者：
Fowler, Amy M.
Rassman, Shane
DeGrave, Michael
Ong, Irene
Powers, Ginny L.
Salem, Kelley
Kumar, Manoj
Woo, Kaitlin
Mahajan, Aparna M.
机构：
[1] Univ Wisconsin Madison, Madison, WI USA
[2] Kendrick Labs Inc, Madison, WI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD8-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
    Amy M. Fowler
    Kelley Salem
    Michael DeGrave
    Irene M. Ong
    Shane Rassman
    Ginny L. Powers
    Manoj Kumar
    Ciara J. Michel
    Aparna M. Mahajan
    Hormones and Cancer, 2020, 11 : 63 - 75
  • [2] Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
    Fowler, Amy M.
    Salem, Kelley
    DeGrave, Michael
    Ong, Irene M.
    Rassman, Shane
    Powers, Ginny L.
    Kumar, Manoj
    Michel, Ciara J.
    Mahajan, Aparna M.
    HORMONES & CANCER, 2020, 11 (02): : 63 - 75
  • [3] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [4] Somatic mutations in steroid hormone receptor coactivators in breast cancer
    Ioan, A. M.
    Epstein, M. S.
    Xia, L. Y.
    Haiman, C. A.
    Press, M. F.
    MODERN PATHOLOGY, 2008, 21 : 39A - 39A
  • [5] Somatic mutations in steroid hormone receptor coactivators in breast cancer
    Ioan, A. M.
    Epstein, M. S.
    Xia, L. Y.
    Haiman, C. A.
    Press, M. F.
    LABORATORY INVESTIGATION, 2008, 88 : 39A - 39A
  • [6] Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer
    Umekita, Y
    Sagara, Y
    Yoshida, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (01): : 27 - 32
  • [7] Emergence of constitutively active estrogen receptor mutations in advanced estrogen receptor positive breast cancer
    Jeselsohn, R. M.
    Yelensky, R.
    Buchwalter, G.
    Frampton, G.
    Meric-Bernstam, F.
    Cristofanilli, M.
    Arteaga, C. L.
    Balko, J.
    Gilmore, L.
    Schnitt, S.
    Come, S. E.
    Pusztai, L.
    Stephens, P.
    Miller, V. A.
    Brown, M.
    CANCER RESEARCH, 2013, 73
  • [8] A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
    Massarweh, Suleiman
    Tham, Yee L.
    Huang, Jian
    Sexton, Krystal
    Weiss, Heidi
    Tsimelzon, Anna
    Beyer, Amanda
    Rimawi, Mothaffar
    Cai, Wei Yen
    Hilsenbeck, Susan
    Fuqua, Suzanne
    Elledge, Richard
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 819 - 827
  • [9] A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
    Suleiman Massarweh
    Yee L. Tham
    Jian Huang
    Krystal Sexton
    Heidi Weiss
    Anna Tsimelzon
    Amanda Beyer
    Mothaffar Rimawi
    Wei Yen Cai
    Susan Hilsenbeck
    Suzanne Fuqua
    Richard Elledge
    Breast Cancer Research and Treatment, 2011, 129
  • [10] Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
    Guttery, David S.
    Page, Karen
    Hills, Allison
    Woodley, Laura
    Marchese, Stephanie D.
    Rghebi, Basma
    Hastings, Robert K.
    Luo, Jinli
    Pringle, J. Howard
    Stebbing, Justin
    Coombes, R. Charles
    Ali, Simak
    Shaw, Jacqueline A.
    CLINICAL CHEMISTRY, 2015, 61 (07) : 974 - 982
12345